Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.

Sanford R, Fernandez Cruz AL, Scott SC, Mayo NE, Fellows LK, Ances BM, Collins DL.

J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):563-570. doi: 10.1097/QAI.0000000000001294.

2.

Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.

J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420.

3.

The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals.

Baker LM, Paul RH, Heaps-Woodruff JM, Chang JY, Ortega M, Margolin Z, Usher C, Basco B, Cooley S, Ances BM.

J Neuroimmune Pharmacol. 2015 Sep;10(3):487-92. doi: 10.1007/s11481-015-9610-4. Epub 2015 Apr 22.

4.

Independent effects of HIV, aging, and HAART on brain volumetric measures.

Ances BM, Ortega M, Vaida F, Heaps J, Paul R.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):469-77. doi: 10.1097/QAI.0b013e318249db17.

5.

Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2011 Aug;17(4):368-79. doi: 10.1007/s13365-011-0033-6. Epub 2011 May 10. Erratum in: J Neurovirol. 2011 Aug;17(4):380-1. Schifitto, Giavoni [corrected to Schifitto, Giovanni].

6.

Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.

Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):289-297. doi: 10.1097/QAI.0000000000001489.

PMID:
28650401
7.

Clinical factors related to brain structure in HIV: the CHARTER study.

Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I; CHARTER Group.

J Neurovirol. 2011 Jun;17(3):248-57. doi: 10.1007/s13365-011-0032-7. Epub 2011 May 5.

8.

Regional brain gray and white matter changes in perinatally HIV-infected adolescents.

Sarma MK, Nagarajan R, Keller MA, Kumar R, Nielsen-Saines K, Michalik DE, Deville J, Church JA, Thomas MA.

Neuroimage Clin. 2013 Oct 29;4:29-34. doi: 10.1016/j.nicl.2013.10.012. eCollection 2014.

9.

Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):374-383.

10.

HIV clades B and C are associated with reduced brain volumetrics.

Ortega M, Heaps JM, Joska J, Vaida F, Seedat S, Stein DJ, Paul R, Ances BM.

J Neurovirol. 2013 Oct;19(5):479-87.

11.

Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.

Ortega M, Brier MR, Ances BM.

AIDS. 2015 Mar 27;29(6):703-12. doi: 10.1097/QAD.0000000000000611.

12.

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.

Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B; HIV Neuroimaging Consortium.

AIDS. 2011 Mar 13;25(5):625-33. doi: 10.1097/QAD.0b013e3283427da7.

13.

Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.

Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, Monaco S, Ferrari S.

J Neurol. 2015 May;262(5):1317-27. doi: 10.1007/s00415-015-7713-8. Epub 2015 Apr 1.

PMID:
25877836
14.

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).

Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.

Dev Neuropsychol. 2006;30(2):633-57.

PMID:
16995830
15.

Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.

Janssen MA, Meulenbroek O, Steens SC, Góraj B, Bosch M, Koopmans PP, Kessels RP.

AIDS. 2015 Oct 23;29(16):2139-48. doi: 10.1097/QAD.0000000000000824.

PMID:
26544578
16.

Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.

Behrman-Lay AM, Paul RH, Heaps-Woodruff J, Baker LM, Usher C, Ances BM.

J Neurovirol. 2016 Feb;22(1):93-103. doi: 10.1007/s13365-015-0373-8. Epub 2015 Aug 26.

17.

Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women.

Crystal HA, Weedon J, Holman S, Manly J, Valcour V, Cohen M, Anastos K, Liu C, Mack WJ, Golub E, Lazar J, Ho A, Kreek MJ, Kaplan RC.

J Neurovirol. 2011 Oct;17(5):469-76. doi: 10.1007/s13365-011-0052-3. Epub 2011 Oct 18.

18.

White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.

Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I; Charter Group.

J Neurovirol. 2009 Apr;15(2):187-95. doi: 10.1080/13550280902769756.

19.

Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study.

Zhu T, Zhong J, Hu R, Tivarus M, Ekholm S, Harezlak J, Ombao H, Navia B, Cohen R, Schifitto G.

J Neurovirol. 2013 Feb;19(1):10-23. doi: 10.1007/s13365-012-0135-9. Epub 2012 Nov 21.

20.

Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease.

Andronikou S, Ackermann C, Laughton B, Cotton M, Tomazos N, Spottiswoode B, Mauff K, Pettifor JM.

Childs Nerv Syst. 2014 Sep;30(9):1549-57. doi: 10.1007/s00381-014-2434-3. Epub 2014 May 23.

PMID:
24853332

Supplemental Content

Support Center